Can I use LigBuilder for DNA-based drug design?
The answer is “NO”. Although DNA-based drug design shares the same concepts with protein-based drug design, there are two reasons preventing you from directly applying LigBuilder to such a project: (1) New parameters are necessary for estimating the DNA-ligand interactions; (2) The binding site of a DNA (minor groove) is more open than a protein (usually a pocket), therefore the construction strategy may also need to be adjusted.